| Authors: |
Schöffski P; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Tan DSW; National Cancer Centre Singapore, Singapore.; Duke-NUS Medical School, Singapore., Martín M; Hospital General Universitario Gregorio Maranon, Madrid, Spain., Ochoa-de-Olza M; Vall d'Hebron University Hospital, Barcelona, Spain., Sarantopoulos J; Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, USA., Carvajal RD; Columbia University Irving Medical Center, New York, New York, USA., Kyi C; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Esaki T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Prawira A; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Akerley W; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., De Braud F; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Hui R; Westmead Hospital and The University of Sydney, Sydney, New South Wales, Australia., Zhang T; University of Texas Southwestern Medical Center, Dallas, Texas, USA., Soo RA; National University Cancer Institute, Singapore., Maur M; Oncologia Medica, AOU Policlinico di Modena, Modena, Emilia-Romagna, Italy., Weickhardt A; Austin Health, Heidelberg, Victoria, Australia., Krauss J; National Center for Tumor Diseases, Heidelberg, Germany., Deschler-Baier B; Universitätsklinikum Würzburg, Wurzburg, Germany., Lau A; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Samant TS; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Longmire T; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Chowdhury NR; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Sabatos-Peyton CA; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Patel N; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Ramesh R; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Hu T; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Carion A; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Gusenleitner D; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Yerramilli-Rao P; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Askoxylakis V; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Kwak EL; Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA dshong@mdanderson.org. |
